Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
DiscGenics Logo
DiscGenics Growth Score
59
CB Rank
28019
Heat Score
53
Regenerative Cell Therapy for Chronic Back Pain.
Founded
obfuscation
PrivateSeries C Salt Lake City, Utah, United States11-50 www.discgenics.com/
Biotechnology
Health Care
Medical
Therapeutics
Overview

DiscGenics
Total Funding
obfuscation
Growth Score
59
Heat Score
53

Total Funding
obfuscation
obfuscation
Series C raised
obfuscation
Growth Score59
-14 pts
in past quarter
Heat Score 53
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About DiscGenics

CB Rank
28019
Regenerative Cell Therapy for Chronic Back Pain.
Founded
obfuscation
PrivateSeries C Salt Lake City, Utah, United States11-50 www.discgenics.com/
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Series C
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name DiscGenics, Inc.
Operating Status Active
Company Type For Profit
Founders  Christopher Duntsch, Flagg Flanagan, John Robertson, Kevin T. Foley, Mark Cohen, Mike Moffat, Rand Page, Valery Kukekov
About the Company
Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Phone Number 801-410-0703
Contact Email info@discgenics.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

IDCT (rebonuputemcel)
An allogeneic, injectable cell therapy using Discogenic Cells to treat mild to moderate lumbar degenerative disc disease via a single intradiscal injection.

Research & Development

DiscGenics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C
obfuscation
Series C - DiscGenics Logo
Series C - DiscGenics
5
obfuscation
Ci:z InvestmentSeries C

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 9 Board Members and Advisors 1 Contacts 38

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

656
-54.98%
 in past month

IT Spend

$475.4KThis year, DiscGenics is projected to spend $475.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
USB (Universal Serial Bus) Logo
USB (Universal Serial Bus)
83
Fake Account Creation Logo
Fake Account Creation
82
Cultivate Logo
Cultivate
81

Actively Used Products

12DiscGenics uses 12 technology products and services including HTML5, GoDaddy Premium DNS, and  Adobe Fonts, according to G2 Stack.

Active Website Tech Count

29DiscGenics is actively using 29 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  HSTS.

Total IP

13The intellectual property of DiscGenics includes 10 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, DiscGenics has registered 3 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is DiscGenics's headquarters? DiscGenics is located in Salt Lake City, Utah, United States.Who invested in DiscGenics? DiscGenics has 5 investors including Mitsubishi UFJ Capital and  Medical Incubator Japan.When was the last funding round for DiscGenics? DiscGenics closed its last funding round on
obfuscation
from a Series C round.Who are DiscGenics's competitors? Alternatives and possible competitors to DiscGenics may include Ocugen, BioRestorative Therapies, and  Spine BioPharma.How much funding has DiscGenics raised to date? DiscGenics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|